| Basics |
Exact Sciences Corporation
Exact Sciences Corp operates in the healthcare sector. It is a diagnostics company focused on the early detection and prevention of colorectal cancer.
|
| IPO Date: |
January 31, 2001 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$19.22B |
| Activated in VL: |
False |
| Average Daily Range |
| Avg Daily Range: |
$0.76 | 2.70%
|
| Avg Daily Range (30 D): |
$1.31 | 1.91%
|
| Avg Daily Range (90 D): |
$0.99 | 1.75%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.25M |
| Avg Daily Volume (30 D): |
6.67M |
| Avg Daily Volume (90 D): |
3.96M |
| Trade Size |
| Avg Trade Size (Sh.): |
101 |
| Avg Trade Size (Sh.) (30 D): |
114 |
| Avg Trade Size (Sh.) (90 D): |
87 |
| Institutional Trades |
| Total Inst.Trades: |
20,831 |
| Avg Inst. Trade: |
$3.29M |
| Avg Inst. Trade (30 D): |
$5.63M |
| Avg Inst. Trade (90 D): |
$4.69M |
| Avg Inst. Trade Volume: |
.06M |
| Avg Inst. Trades (Per Day): |
7 |
| Market Closing Trades |
| Avg Closing Trade: |
$10.49M |
| Avg Closing Trade (30 D): |
$25.28M |
| Avg Closing Trade (90 D): |
$19.45M |
| Avg Closing Volume: |
180.87K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
|
$-.1
|
$-.01
|
|
Diluted EPS
|
|
$-.1
|
$-.01
|
|
Revenue
|
$
|
$ 850.74M
|
$ 811.09M
|
|
Gross Profit
|
$
|
$ 583.93M
|
$ 562.45M
|
|
Net Income / Loss
|
$
|
$ -19.59M
|
$ -1.19M
|
|
Operating Income / Loss
|
$
|
$ -25.55M
|
$ -2.15M
|
|
Cost of Revenue
|
$
|
$ 266.81M
|
$ 248.63M
|
|
Net Cash Flow
|
$
|
$ 131.94M
|
$ 309.97M
|
|
PE Ratio
|
|
|
|
|
|
|
